Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Bicalutamide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bicalutamide 50mg tablets
0803042A0AAAAAA
|
Bicalutamide | Bicalutamide | Malignant Disease and Immunosuppression | 35,808 |
|
Bicalutamide 150mg tablets
0803042A0AAABAB
|
Bicalutamide | Bicalutamide | Malignant Disease and Immunosuppression | 24,708 |
|
Casodex 50mg tablets
0803042A0BBAAAA
|
Casodex | Bicalutamide | Malignant Disease and Immunosuppression | 110 |
|
Casodex 150mg tablets
0803042A0BBABAB
|
Casodex | Bicalutamide | Malignant Disease and Immunosuppression | 73 |
|
Bicalutamide 150mg/5ml oral suspension
0803042A0AAADAD
|
Bicalutamide | Bicalutamide | Malignant Disease and Immunosuppression | No data available |
|
Bicalutamide 50mg/5ml oral suspension
0803042A0AAACAC
|
Bicalutamide | Bicalutamide | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.